EzeRx has signed a Memorandum of Understanding (MoU) with IMGENEX India to make quality medical care affordable and accessible to all Indians, according to a statement from EzeRx.
The statement said that the duo aim to develop cutting-edge screening and diagnostic solutions that are indigenous, low-cost and effective. This partnership unites technical prowess with purpose, applying technology to bridge gaps in preventive care and early diagnosis.
Commenting on the agreement, Partha Pratim Das Mahapatra, CEO, EzeRx, said in the statement, “We are thrilled to partner with IMGENEX India in working towards healthcare equity and empowerment. By combining our complementary strengths, we hope to reshape the delivery of care with ‘Made in India’ products that set new benchmarks in quality, affordability and scalability.”
EzeRx has previously partnered with companies like TCS, Infosys Foundation and Indian Oil Corporation. However, this partnership with IMGENEX holds special significance for advancing indigenous manufacturing and Research and Development (R&D) in healthcare.
The MoU outlines joint initiatives to provide low-cost, effective and privacy-protected screening solutions, particularly for diseases affecting women. This partnership aims to transform healthcare access across India and also explore global opportunities. Together, EzeRx and IMGENEX aim to develop India-centric solutions that set a benchmark in quality, cost-effectiveness and scalability.
Echoing similar views, Dr Sujay Singh, Founder, IMGENEX India, also said in the statement, “We are excited to apply our biotechnology expertise to create affordable innovations that solve real challenges. Together with EzeRx, we will develop products that improve health outcomes across the country.”
